Search results
Kamala Harris could be part of an all-female ticket to challenge Donald Trump
The Irish Times· 3 days agoThe week has generated such a blizzard of speculation and controversy in American politics that a...
Are rich people at greater genetic risk for cancer? What the experts say
NY Post· 3 days agoFor this study, genetic, health and socioeconomic (defined as educational achievement and...
Euro 2024 final: Alex Keble's match-ups and key battles
Sporting Life· 3 days agoThis...That is the rough blueprint for how England can overcome the odds to produce a smash-and-grab...
The Democrats Are Making a Terrible Mistake
New York Magazine· 3 days agoThe Supreme Court would rule that he is entitled to commit crimes in office. Joe Biden is the only candidate standing (if we define the term loosely)...
Olfactory ensheathing cell transplantation as a strategy for spinal cord repair—what can it achieve?...
Nature· 3 days agoNumerous lines of evidence from animal studies indicate that transplants of olfactory ensheathing cells—glial cells derived from the olfactory system—can promote functional recovery in the injured ...
PARTNER | Bridging data silos for personalised services in local government
PublicTechnology.net· 3 days agoLocal governments are challenged by data fragmentation and the need for personalisation in the...
Centrosome biogenesis and function: centrosomics brings new understanding - Nature Reviews Molecular...
Nature· 3 days agoRecent large-scale functional genomics and proteomics analyses have revealed novel molecules that are involved in regulating centrosome function and biogenesis. Other studies indicate that certain ...
Pioneering oral delivery for gene therapy
Nature· 3 days agoMucosal tissues are challenging to treat using current delivery approaches for protein therapies. It is difficult to achieve a sufficient concentration...
Creating next-generation RNA-targeting therapeutics
Nature· 3 days agoDTx Pharma, Inc., a privately held biotechnology company located in San Diego, CA, and founded in 2018, has developed a proprietary technology platform to enable the delivery of novel RNA-based ...
Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation...
Nature· 4 days agoSuperantigens trigger an excessive cellular immune response, leading to toxic shock. We have designed a peptide antagonist that inhibits superantigen-induced expression of human genes for interleukin ...
